We narrowed to 3,022 results for: Rho;

1. Anti-SARS-CoV-2 Nucleocapsid Protein [mBG17] (Recombinant Antibody)

   Antibody

   #211756-rAb

   Purpose

   Recombinant mouse monoclonal Anti-SARS-CoV-2 nucleocapsid protein antibody

   Depositor

   Brian Geiss

   Article

   Terry et al Virology. 2021 Jun;558:28-37. doi: 10.10

   Recommended Applications

   Western Blot

   Reactivity

   Source Species

   Mouse

   Isotype

   IgG2a

   Trial Size

   Not available to purchase

   Available Since

   March 14, 2024

   Availability

   Industry, Academic Institutions, and Nonprofits

   

2. Anti-SARS-CoV-2 Nucleocapsid Protein [mBG86] (Recombinant Antibody)

   Antibody

   #211757-rAb

   Purpose

   Recombinant mouse monoclonal Anti-SARS-CoV-2 nucleocapsid protein antibody

   Depositor

   Brian Geiss

   Article

   Terry et al Virology. 2021 Jun;558:28-37. doi: 10.10

   Recommended Applications

   Western Blot

   Reactivity

   Source Species

   Mouse

   Isotype

   IgG2a

   Trial Size

   Not available to purchase

   Available Since

   March 14, 2024

   Availability

   Industry, Academic Institutions, and Nonprofits

   

3. Anti-Beta-2-microglobulin [BBM.1] (Recombinant Antibody)

   Antibody

   #207115-rAb

   Purpose

   Anti-Beta-2-microglobulin [BBM.1] (Human) recombinant mouse monoclonal antibody

   Depositor

   Melina Fan

   Article

   Brodsky et al Eur J Immunol. 1979 Jul;9(7):536-45. doi

   Recommended Applications

   Immunocytochemistry

   Reactivity

   Human

   Source Species

   Mouse

   Isotype

   IgG2a

   Trial Size

   Available to purchase

   Available Since

   Nov. 22, 2024

   Availability

   Industry, Academic Institutions, and Nonprofits

   

4. Anti-CD4 [mu5A8] (Recombinant Antibody)

   Antibody

   #212327-rAb

   Purpose

   Anti-CD4 (Human) recombinant mouse monoclonal antibody

   Depositor

   Melina Fan

   Article

   Burkly et al J Immunol. 1992 Sep 1;149(5):1779-87.

   Recommended Applications

   Western Blot

   Reactivity

   Human

   Source Species

   Mouse

   Isotype

   IgG2a

   Trial Size

   Available to purchase

   Available Since

   June 5, 2024

   Availability

   Industry, Academic Institutions, and Nonprofits

   

5. AiP13775 - pAAV-AiE0050m_3xC2-minBG-iCre-BGHpA (Alias: CN3775)

   Plasmid

   #230379

   Purpose

   AiE0050m_3xC2 is an enhancer sequence, designed to drive AAV-mediated transgene expression in specific populations of brain cells

   Depositor

   Jonathan Ting, Allen Institute for Brain Science

   Article

   Ben-Simon et al Cell. 2025 May 16:S0092-8674(25)00513-6.

   Insert

   iCre
   

   Use

   AAV

   Tags

   Expression

   Mutation

   Promoter

   minRho

   Available Since

   Feb. 20, 2025

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

6. AiP12218 - pAAV-AiE0058h_3xC2-minCMV-SYFP2-WPRE3-BGHpA (Alias: CN2218)

   Plasmid

   #230358

   Purpose

   AiE0058h_3xC2 is an enhancer sequence, designed to drive AAV-mediated transgene expression in specific populations of brain cells

   Depositor

   Jonathan Ting, Allen Institute for Brain Science

   Article

   Ben-Simon et al Cell. 2025 May 16:S0092-8674(25)00513-6.

   Insert

   SYFP2
   

   Use

   AAV

   Tags

   Expression

   Mutation

   Promoter

   minRho

   Available Since

   Feb. 20, 2025

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

7. AiP13786 - pAAV-AiE0140h-minBG-iCre(R297T)-BGHpA (Alias: CN3786)

   Plasmid

   #230382

   Purpose

   AiE0140h is an enhancer sequence, designed to drive AAV-mediated transgene expression in specific populations of brain cells

   Depositor

   Jonathan Ting, Allen Institute for Brain Science

   Article

   Ben-Simon et al Cell. 2025 May 16:S0092-8674(25)00513-6.

   Insert

   iCre(R297T)
   

   Use

   AAV

   Tags

   Expression

   Mutation

   Promoter

   minRho

   Available Since

   Feb. 24, 2025

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

8. AiP13776 - pAAV-AiE0050m_3xC2-minBG-iCre-WPRE3-BGHpA (Alias: CN3776)

   Plasmid

   #230380

   Purpose

   AiE0050m_3xC2 is an enhancer sequence, designed to drive AAV-mediated transgene expression in specific populations of brain cells

   Depositor

   Jonathan Ting, Allen Institute for Brain Science

   Article

   Ben-Simon et al Cell. 2025 May 16:S0092-8674(25)00513-6.

   Insert

   iCre
   

   Use

   AAV

   Tags

   Expression

   Mutation

   Promoter

   minRho

   Available Since

   Feb. 24, 2025

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

9. AiP13602 - pAAV-AiE0600m_3xC2-minBG-SYFP2-WPRE3-BGHpA (Alias: CN3602)

   Plasmid

   #230378

   Purpose

   AiE0600m_3xC2 is an enhancer sequence, designed to drive AAV-mediated transgene expression in specific populations of brain cells

   Depositor

   Jonathan Ting, Allen Institute for Brain Science

   Article

   Ben-Simon et al Cell. 2025 May 16:S0092-8674(25)00513-6.

   Insert

   SYFP2
   

   Use

   AAV

   Tags

   Expression

   Mutation

   Promoter

   minRho

   Available Since

   Feb. 20, 2025

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

10. AiP13784 - pAAV-AiE0526h-minBG-iCre(R297T)-BGHpA (Alias: CN3784)

    Plasmid

    #230381

    Purpose

    AiE0526h is an enhancer sequence, designed to drive AAV-mediated transgene expression in specific populations of brain cells

    Depositor

    Jonathan Ting, Allen Institute for Brain Science

    Article

    Ben-Simon et al Cell. 2025 May 16:S0092-8674(25)00513-6.

    Insert

    iCre(R297T)
    

    Use

    AAV

    Tags

    Expression

    Mutation

    Promoter

    minRho

    Available Since

    Feb. 24, 2025

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

11. AiP13788 - pAAV-AiE0121h-minBG-iCre(R297T)-BGHpA (Alias: CN3788)

    Plasmid

    #230383

    Purpose

    AiE0121h is an enhancer sequence, designed to drive AAV-mediated transgene expression in specific populations of brain cells

    Depositor

    Jonathan Ting, Allen Institute for Brain Science

    Article

    Ben-Simon et al Cell. 2025 May 16:S0092-8674(25)00513-6.

    Insert

    iCre(R297T)
    

    Use

    AAV

    Tags

    Expression

    Mutation

    Promoter

    minRho

    Available Since

    Feb. 20, 2025

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

12. AiP11461 - pAAV-AiE0073m-minBG-SYFP2-WPRE3-BGHpA (Alias: CN1461)

    Plasmid

    #230353

    Purpose

    AiE0073m is an enhancer sequence, designed to drive AAV-mediated transgene expression in specific populations of brain cells

    Depositor

    Jonathan Ting, Allen Institute for Brain Science

    Article

    Ben-Simon et al Cell. 2025 May 16:S0092-8674(25)00513-6.

    Insert

    SYFP2
    

    Use

    AAV

    Tags

    Expression

    Mutation

    Promoter

    minRho

    Available Since

    Feb. 20, 2025

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

13. pAAV_hSyn_WiChR_TS_mScarlet_ER (AAV9)

    Viral Prep

    #205997-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV_hSyn_WiChR_TS_mScarlet_ER (#205997). In addition to the viral particles, you will also receive purified pAAV_hSyn_WiChR_TS_mScarlet_ER plasmid DNA. hSyn-driven K+ selective channelrhodopsin for optogenetic inhibition of neurons. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Johannes Vierock, Peter Hegemann

    Article

    Vierock et al Sci Adv. 2022 Nov 16:eadd7729.

    Promoter

    Syn

    Tags

    mScarlet

    Available Since

    July 30, 2025

    Availability

    Academic Institutions and Nonprofits only

14. pAAV_hSyn1-SIO-stGtACR2-FusionRed (AAV5)

    Viral Prep

    #105677-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pAAV_hSyn1-SIO-stGtACR2-FusionRed (#105677). In addition to the viral particles, you will also receive purified pAAV_hSyn1-SIO-stGtACR2-FusionRed plasmid DNA. Synapsin-driven, Cre-dependent, soma-targeted anion-conducting channelrhodopsin fused to FusionRed for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Ofer Yizhar

    Article

    Mahn et al Nat Commun. 2018 Oct 8;9(1):4125. doi: 1

    Promoter

    Syn

    Tags

    FusionRed (Cre-dependent)

    Available Since

    Oct. 21, 2024

    Availability

    Academic Institutions and Nonprofits only

15. pAAV_hSyn1-SIO-stGtACR1-FusionRed (AAV5)

    Viral Prep

    #105678-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pAAV_hSyn1-SIO-stGtACR1-FusionRed (#105678). In addition to the viral particles, you will also receive purified pAAV_hSyn1-SIO-stGtACR1-FusionRed plasmid DNA. Synapsin-driven, Cre-dependent, soma-targeted anion-conducting channelrhodopsin fused to FusionRed for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Ofer Yizhar

    Article

    Mahn et al Nat Commun. 2018 Oct 8;9(1):4125. doi: 1

    Promoter

    Syn

    Tags

    FusionRed (Cre-dependent)

    Available Since

    Sept. 24, 2020

    Availability

    Academic Institutions and Nonprofits only

16. pAAV-CKIIa-stGtACR2-FusionRed (AAV1)

    Viral Prep

    #105669-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-CKIIa-stGtACR2-FusionRed (#105669). In addition to the viral particles, you will also receive purified pAAV-CKIIa-stGtACR2-FusionRed plasmid DNA. CaMKIIa-driven, soma-targeted anion-conducting channelrhodopsin fused to FusionRed for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Ofer Yizhar

    Article

    Mahn et al Nat Commun. 2018 Oct 8;9(1):4125. doi: 1

    Promoter

    CaMKII

    Tags

    FusionRed

    Available Since

    July 17, 2018

    Availability

    Academic Institutions and Nonprofits only

17. pAAV_hSyn1-SIO-stGtACR2-FusionRed (AAV1)

    Viral Prep

    #105677-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV_hSyn1-SIO-stGtACR2-FusionRed (#105677). In addition to the viral particles, you will also receive purified pAAV_hSyn1-SIO-stGtACR2-FusionRed plasmid DNA. Synapsin-driven, Cre-dependent, soma-targeted anion-conducting channelrhodopsin fused to FusionRed for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Ofer Yizhar

    Article

    Mahn et al Nat Commun. 2018 Oct 8;9(1):4125. doi: 1

    Promoter

    Syn

    Tags

    FusionRed (Cre-dependent)

    Available Since

    Aug. 17, 2018

    Availability

    Academic Institutions and Nonprofits only

18. pAAV-CKIIa-stGtACR2-FusionRed (AAV Retrograde)

    Viral Prep

    #105669-AAVrg

    Purpose

    Ready-to-use AAV Retrograde particles produced from pAAV-CKIIa-stGtACR2-FusionRed (#105669). In addition to the viral particles, you will also receive purified pAAV-CKIIa-stGtACR2-FusionRed plasmid DNA. CaMKIIa-driven, soma-targeted anion-conducting channelrhodopsin fused to FusionRed for optogenetic inhibition. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Ofer Yizhar

    Article

    Mahn et al Nat Commun. 2018 Oct 8;9(1):4125. doi: 1

    Promoter

    CaMKII

    Tags

    FusionRed

    Available Since

    July 8, 2020

    Availability

    Academic Institutions and Nonprofits only

19. pAAV_hSyn1-SIO-stGtACR2-FusionRed (AAV Retrograde)

    Viral Prep

    #105677-AAVrg

    Purpose

    Ready-to-use AAV Retrograde particles produced from pAAV_hSyn1-SIO-stGtACR2-FusionRed (#105677). In addition to the viral particles, you will also receive purified pAAV_hSyn1-SIO-stGtACR2-FusionRed plasmid DNA. Synapsin-driven, Cre-dependent, soma-targeted anion-conducting channelrhodopsin fused to FusionRed for optogenetic inhibition. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Ofer Yizhar

    Article

    Mahn et al Nat Commun. 2018 Oct 8;9(1):4125. doi: 1

    Promoter

    Syn

    Tags

    FusionRed (Cre-dependent)

    Available Since

    July 8, 2020

    Availability

    Academic Institutions and Nonprofits only

20. pAAV-double floxed-eNpHR-EYFP-WPRE-pA (AAV9)

    Viral Prep

    #20949-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-double floxed-eNpHR-EYFP-WPRE-pA (#20949). In addition to the viral particles, you will also receive purified pAAV-double floxed-eNpHR-EYFP-WPRE-pA plasmid DNA. EF1a-driven, cre-dependent eNpHR EYFP for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Promoter

    EF1a

    Tags

    EYFP (Cre-dependent)

    Available Since

    July 12, 2018

    Availability

    Academic Institutions and Nonprofits only